HIT Consultant

AUGUST 5, 2022

What You Should Know: – The index of Healthcare & Life Science equities tracked by Stout was down 16.8% – Healthcare & Life Science M&A activity plummeted to 338 deals in Q2 2022 versus 535 in Q2 2021 and a record 565 deals in Q4 2021. Medical Device equities were down 18.5%

Life Sciences 98

Life Sciences Telemedicine Healthcare Biotechnology 98

HIT Consultant

NOVEMBER 18, 2021

Benchling , a San Francisco, CA-based life and sciences R&D cloud platform raises $100M in Series F funding at a $6B valuation, co-led by new investor Franklin Templeton and existing investor Altimeter Capital , and joined by new investors Tiger Global and Lone Pine Capital , as well as existing investors.

Biotechnology 97

Biotechnology Life Sciences Pharmaceuticals Accountability 97

HIT Consultant

JANUARY 28, 2022

Benchling , pioneer of the R&D Cloud powering the biotechnology industry appoints Paul Robson, a cloud veteran as President of Field Operations and Elena Donio, the former CEO of Axiom and President of Concur, to its board, as a director and compensation committee chair. . – Leah Ray , Chief Customer Officer.

Biotechnology 98

Biotechnology Life Sciences Private Practices Pharmaceuticals 98

HIT Consultant

OCTOBER 22, 2021

Hawkes, who joined Caravan Health in 2017, will continue his role as the head of product, infrastructure, and info-security while adding data and analytics along with accountable care organization (ACO) production information and strategic planning and leadership. Professor Joe Kvedar . revolutionary?tools?to?advance Oculis appoints Dr.

Biotechnology 52

Biotechnology Life Sciences Accountability Accountable Care 52